Advertisement

Use of adenosine in patients hospitalized in a university medical center

      Abstract

      Purpose: Adenosine is a useful agent for the diagnosis and termination of tachycardias. The purpose of this study was to identify the rhythms for which adenosine is prescribed in hospitalized adults and to identify the reasons for its misuse.
      Patients and Methods: Data were collected from the medical records of 100 patients who received intravenous adenosine while hospitalized at a university medical center. The characteristics of the patients, rhythms treated with adenosine, and dosages of adenosine were analyzed. In addition, internal medicine house officers were administered a questionnaire referring to an electrocardiogram of atrial fibrillation with a rapid ventricular response.
      Results: The arrhythmias for which adenosine was administered consisted of regular, narrow-QRS complex tachycardias in 33% of patients; atrial fibrillation in 32% of patients; regular, wide-QRS complex tachycardias in 23% of patients; atrial flutter in 10% of patients, and multifocal atrial tachycardia in 2% of patients. The mean (± SD) number of doses of adenosine given to each patient was 1.6 ± 0.8, and the mean dose of adenosine was 7.8 ± 2.8 mg. Internal medicine house officers prescribed 70% of the doses of adenosine and were as likely to use it for patients with atrial fibrillation as were surgical house officers. There was a 2% incidence of proarrhythmia, including asystole and polymorphic ventricular tachycardia. Thirty-one percent of the 100 house officers in our survey misdiagnosed a 12-lead electrocardiogram of rapid atrial fibrillation as paroxysmal supraventricular tachycardia, suggesting that adenosine may have been misused for atrial fibrillation because of errors in rhythm diagnosis. Only 5% of those who correctly diagnosed atrial fibrillation also answered that adenosine would be likely to terminate the arrhythmia, suggesting that a misunderstanding that adenosine terminates atrial fibrillation is not a common reason for its misuse.
      Conclusions: Approximately 40% of hospitalized adults who are treated with adenosine receive the medication unnecessarily for atrial fibrillation or atrial flutter, and this misuse results in unnecessary expenses and risks of adverse effects. The primary reason that adenosine is misused for atrial fibrillation is the inability to recognize that rhythm on an electrocardiogram. House officers need additional education on the electrocardiographic recognition of atrial fibrillation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • DiMarco J.P.
        • Sellers D.
        • Lerman B.B.
        • et al.
        Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.
        J Am Coll Cardiol. 1985; 6: 417-425
        • DiMarco J.P.
        • Miles W.
        • Akhtar M.
        • et al.
        • for the Adenosine for PSVT Study Group
        Adenosine for paroxysmal supraventricular tachycardia.
        Ann Intern Med. 1990; 113: 104-110
        • Hood M.A.
        • Smith W.M.
        Adenosine versus verapamil in the treatment of supraventricular tachycardia.
        Am Heart J. 1992; 123: 1543-1549
        • Cairns C.B.
        • Niemann J.T.
        Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia.
        Ann Emerg Med. 1991; 20: 717-721
        • Marco C.A.
        • Cardinale J.F.
        Adenosine for the treatment of supraventricular tachycardia in the ED.
        Am J Emerg Med. 1994; 12: 485-488
        • Rossi A.F.
        • Steinberg G.L.
        • Kipel G.
        • et al.
        Use of adenosine in the management of perioperative arrhythmias in the pediatric cardiac intensive care unit.
        Crit Care Med. 1992; 20: 1107-1111
        • Brady W.J.
        • DeBehnke D.J.
        • Wickman L.L.
        • Lindbeck G.
        Treatment of out-of-hospital supraventricular tachycardia.
        Acad Emerg Med. 1996; 3: 574-585
        • Camm A.J.
        • Garratt C.J.
        Adenosine and supraventricular tachycardia.
        NEJM. 1991; 325: 1621-1629
        • Rankin A.C.
        • Brooks R.
        • Ruskin J.
        • McGovern B.A.
        Adenosine and the treatment of supraventricular tachycardia.
        Am J Cardiol. 1992; 92: 655-664
      1. Bigger JT. Cardiac arrhythmias. In: Wyngaarden JB, Smith LH, Bennett JC, eds. Cecil Textbook of Medicine. 20th ed. Philadelphia: WB Sanders; 1996:240–241.

      2. Zipes DP. Cardiac arrhythmias. In: Kelley WN, ed. Textbook of Internal Medicine. 3rd ed. Philadelphia: JB Lippincott; 1997:416–417.

      3. Josephson ME, Zimetbaum P, Buxton AE, Marchlinski FE. The tachyarrhythmias. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison’s Principles of Internal Medicine. 14th ed. New York: McGraw-Hill; 1998:1264–1265.

        • Kastor J.A.
        Multifocal atrial tachycardia.
        NEJM. 1990; 322: 24:1713-24:1717
      4. Zipes DP. Specific arrhythmias: diagnosis and treatment. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 4th ed. Philadelphia: WB Saunders; 1992.

        • Cushley M.J.
        • Tattersfield A.E.
        • Holgate S.T.
        Adenosine-induced bronchospasm in asthma. Antagonism by inhaled theophylline.
        Am Rev Respir Dis. 1984; 129: 380-384
        • Nunain S.O.
        • Garratt C.
        • Paul V.
        • et al.
        Effect of intravenous adenosine on human atrial and ventricular repolarisation.
        Cardiovasc Res. 1992; 26: 939-943
        • Tebbenjohanns J.
        • Pfeiffer D.
        • Schumacher B.
        • et al.
        Intravenous adenosine during atrioventricular reentrant tachycardia.
        PACE. 1995; 18: 743-746
        • Exner D.V.
        • Muzyka T.
        • Gillis A.M.
        Proarrhythmia in patients with the Wolff-Parkinson-White syndrome after standard doses of intravenous adenosine.
        Ann Intern Med. 1995; 122: 351-352
        • Garratt C.J.
        • O’Nunain S.
        • Griffith M.
        • et al.
        Effects of intravenous adenosine in patients with preexcited junctional tachycardias.
        Am J Cardiol. 1994; 74: 401-404
        • Strickberger S.A.
        • Man K.C.
        • Daoud E.G.
        • et al.
        Adenosine-induced atrial arrhythmia.
        Ann Intern Med. 1997; 127: 417-422
        • Orebaugh S.L.
        • Handy M.
        Intravenous adenosine therapy accelerating rate of paroxysmal supraventricular tachycardia.
        Am J Emerg Med. 1992; 10: 326-330
        • Slade A.K.B.
        • Garret C.J.
        Proarrhythmic effect of adenosine in a patient with atrial flutter.
        Br Heart J. 1993; 70: 91-92
        • Rankin A.C.
        • Rae A.P.
        • Houston A.
        Acceleration of ventricular response to atrial flutter after intravenous adenosine.
        Br Heart J. 1993; 69: 263-265
        • Brodsky M.A.
        • Hwang C.
        • Hunter D.
        • et al.
        Life-threatening alterations in heart rate after the use of adenosine in atrial flutter.
        Am Heart J. 1995; 130: 546-571
        • Smith J.R.
        • Goldberger J.J.
        • Kadish A.H.
        Adenosine induced polymorphic ventricular tachycardia in adults without structural heart disease.
        PACE. 1997; 20: 743-745